Novo increases digital effort: "We want to be leading in the field"

Novo Nordisk expands the workforce to develop of digital products such as insulin pens registering doses in an app. The goal is to beat the competition from Eli Lilly and Sanofi.

Photo: Novo Nordisk / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles